{"uri":"/api/stitches/v1/1JQS135EYN.json","count":6,"data":[{"CompoundDescriptionUri":["https://www.ncbi.nlm.nih.gov/pubmed/11274341"],"InVitroUseGuide":["Using the BV-2 microglial cell line and primary mouse microglia, it was found that oxytocin (0.1, 1, and 10 μM) pre-treatment significantly inhibited LPS-induced microglial activation and reduced subsequent release of pro-inflammatory factors."],"OriginatorUri":["https://www.ncbi.nlm.nih.gov/pubmed/16994116/","https://www.ncbi.nlm.nih.gov/pubmed/13305558/"],"ModifiedDateTime":["2017-02-02"],"Cns":["CNS Active"],"InVivoUseRouteOther":["Intravenous infusion or intramuscular injection"],"InVitroUri":["https://www.ncbi.nlm.nih.gov/pubmed/27075756"],"ChemblId":["CHEMBL395429"],"Conditions":["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","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"],"OriginatorComment":["references retrieved from","https://www.ncbi.nlm.nih.gov/pubmed/24141993"],"ChemSpiderID":["388434"],"InVivoUseGuide":["The dosage of (Oxytocin Injection, USP) Synthetic is determined by the uterine response and must therefore be individualized and initiated at a very low level. The following dosage information is based upon various regimens and indications in general use. A. Induction or Stimulation of Labor Intravenous infusion (drip method) is the only acceptable method of parenteral administration of Pitocin for the induction or stimulation of labor. Accurate control of the rate of infusion is essential and is best accomplished by an infusion pump. It is convenient to piggyback the Pitocin infusion on a physiologic electrolyte solution, permitting the Pitocin infusion to be stopped abruptly without interrupting the electrolyte infusion. This is done in the following way. 1. Preparation a. The standard solution for infusion of Pitocin is prepared by adding the contents of one 1-mL vial containing 10 units of oxytocin to 1000 mL of 0.9% aqueous sodium chloride or Ringer's lactate. The combined solution containing 10 milliunits (mU) of oxytocin/mL is rotated in the infusion bottle for thorough mixing. b. Establish the infusion with a separate bottle of physiologic electrolyte solution not containing Pitocin. c. Attach (piggyback) the Pitocin-containing bottle with the infusion pump to the infusion line as close to the infusion site as possible. 2. Administration The initial dose should be 0.5–1 mU/min (equal to 3–6 mL of the dilute oxytocin solution per hour). At 30–60 minute intervals the dose should be gradually increased in increments of 1–2 mU/min until the desired contraction pattern has been established. Once the desired frequency of contractions has been reached and labor has progressed to 5–6 cm dilation, the dose may be reduced by similar increments. Studies of the concentrations of oxytocin in the maternal plasma during Pitocin infusion have shown that infusion rates up to 6 mU/min give the same oxytocin levels that are found in spontaneous labor. At term, higher infusion rates should be given with great care, and rates exceeding 9–10 mU/min are rarely required. Before term, when the sensitivity of the uterus is lower because of a lower concentration of oxytocin receptors, a higher infusion rate may be required. 3. Monitoring a. Electronically monitor the uterine activity and the fetal heart rate throughout the infusion of Pitocin. Attention should be given to tonus, amplitude and frequency of contractions, and to the fetal heart rate in relation to uterine contractions. If uterine contractions become too powerful, the infusion can be abruptly stopped, and oxytocic stimulation of the uterine musculature will soon wane (see PRECAUTIONS section). b. Discontinue the infusion of Pitocin immediately in the event of uterine hyperactivity and/or fetal distress. Administer oxygen to the mother, who preferably should be put in a lateral position. The condition of mother and fetus should immediately be evaluated by the responsible physician and appropriate steps taken.  B. Control of Postpartum Uterine Bleeding 1. Intravenous infusion (drip method). If the patient has an intravenous infusion running, 10 to 40 units of oxytocin may be added to the bottle, depending on the amount of electrolyte or dextrose solution remaining (maximum 40 units to 1000 mL). Adjust the infusion rate to sustain uterine contraction and control uterine atony. 2. Intramuscular administration. (One mL) Ten (10) units of Pitocin can be given after the delivery of the placenta. C. Treatment of Incomplete, Inevitable, or Elective Abortion Intravenous infusion of 10 units of Pitocin added to 500 mL of a physiologic saline solution or 5% dextrose-in-water solution may help the uterus contract after a suction or sharp curettage for an incomplete, inevitable, or elective abortion. Subsequent to intra-amniotic injection of hypertonic saline, prostaglandins, urea, etc., for midtrimester elective abortion, the injection-to-abortion time may be shortened by infusion of Pitocin at the rate of 10 to 20 milliunits (20 to 40 drops) per minute. The total dose should not exceed 30 units in a 12-hour period due to the risk of water intoxication."],"Originator":["By 1930 Oxytocin was separated, at Parke Davis. By 1955, Sequenced and synthesized by Vincent du Vigneaud."],"id":"OXYTOCIN","CnsUri":["https://www.ncbi.nlm.nih.gov/pubmed/11274341"],"Cid":["439302"],"Wikiurl":["https://en.wikipedia.org/wiki/Oxytocin"],"COMPOUND_QCD":["false"],"Pmids":["19960062","19943928","1983356","19780418","19748597","19725953","19703279","19655687","19603316","19568068","19560473","19528263","19527382","19397506","19371575","19288895","19111230","19077291","18803892","18655559","18642564","18513945","18470320","18405156","18393014","18385263","18298506","18259898","17877597","17662152","17426793","17332197","17230289","17176279","17081295","17072839","17057297","16920323","16904652","16869966","16827957","16759384","16645560","16499031","16260206","16173837","16158071","16041629","16008884","15971561","1596750","15909422","15846688","15774080","15687944","15581725","15577731","15559719","15547535","15470335","15387857","15282001","15223161","14712990","14705714","14567163","1358647","12946338","12859506","12850620","12824972","12757361","12660315","12638569","12144723","12113966","11906527","11905429","11883027","11883025","11883024","11871004","11866697","11787915","11787914","11750957","11579162","11577783","11573116","11531635","1153152","11524621","11489462","11449831","11435005","11288059","11240523","11207490","10704759","10519430","1033698"],"CompoundName":["OXYTOCIN"],"CompoundSynonym":["OXYTOCIN CITRATE","GLYCINAMIDE, L-CYSTEINYL-L-TYROSYL-L-ISOLEUCYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LEUCYL-, CYCLIC (1->6)-DISULFIDE","OXITOCINA","OXYTOCIN","OXYTOCINE","OXYTOCINUM","PITOCIN","SYNTOCINON","ОКСИТОЦИН","أوكسيتوسين","缩宫素","OXYTOCIN ACETATE","OXYTOCIN MONOACETATE","OXYTOCIN, ACETATE (1:1)","OXYTOCIN, MONOACETATE (SALT)","BUCCAL","OXYTOCIN, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1) (SALT)","OXYTOCIN, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (SALT)","OXYTOCIN, CITRATE","PITOCIN CITRATE","PITOCIN-BUCCAL","CYS-TYR-ILE-GLN-ASN-CYS-PRO-LEU-GLY-NH2 (1-6)","CYS-TYR-ILE-GLN-ASN-CYS-PRO-LEU-GLY-NH2, CYCLIC 1-6 DISULFIDE","OXYMETRIN","SYNTOMETRINE","GR-121619","OPN-300","TI-001 (INTRANASAL)","TUR-001","VAGITOCIN","CHEMBL395429"],"CompoundSmiles":["CCC(C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O"],"InVivoUri":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018261s031lbl.pdf"],"StructureAlert":["Unknown"],"Targets":["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"],"SMILES":"CCC(C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O","BindingdbId":["50205990"],"KeggId":["D00089"],"Unii":["1JQS135EYN","4NR672T8NL","1573L6WJ8U"],"Cas":["50-56-6"],"Completed":["true"],"MOLFILE":"\n  Marvin  11091707350D          \n\n 69 71  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  3  5  1  0  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  7  8  2  0  0  0  0\n  7  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  3  0  0  0\n 12 13  1  0  0  0  0\n 13 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  2  3  0  0  0\n 11 17  1  0  0  0  0\n  9 18  1  0  0  0  0\n 18 19  1  0  0  0  0\n 19 20  2  0  0  0  0\n 19 21  1  0  0  0  0\n 21 22  1  0  0  0  0\n 21 23  1  0  0  0  0\n 23 24  1  0  0  0  0\n 24 25  1  0  0  0  0\n 25 26  1  0  0  0  0\n 26 27  1  0  0  0  0\n 27 28  1  0  0  0  0\n 28 29  1  0  0  0  0\n 29 30  2  0  0  0  0\n 29 31  1  0  0  0  0\n 31 32  1  0  0  0  0\n 32 33  1  0  0  0  0\n 33 34  1  0  0  0  0\n 33 35  2  0  0  0  0\n 31 36  1  0  0  0  0\n 36 37  1  0  0  0  0\n 37 38  2  0  0  0  0\n 37 39  1  0  0  0  0\n 39 40  1  0  0  0  0\n 40 41  1  0  0  0  0\n 41 42  1  0  0  0  0\n 42 43  1  0  0  0  0\n 42 44  2  0  0  0  0\n 39 45  1  0  0  0  0\n 45 46  1  0  0  0  0\n  5 46  1  0  0  0  0\n 46 47  2  0  0  0  0\n 27 48  1  0  0  0  0\n 48 49  2  0  0  0  0\n 48 50  1  0  0  0  0\n 50 51  1  0  0  0  0\n 51 52  1  0  0  0  0\n 52 53  1  0  0  0  0\n 53 54  1  0  0  0  0\n 50 54  1  0  0  0  0\n 54 55  1  0  0  0  0\n 55 56  2  0  0  0  0\n 55 57  1  0  0  0  0\n 57 58  1  0  0  0  0\n 58 59  1  0  0  0  0\n 59 60  1  0  0  0  0\n 60 61  1  0  0  0  0\n 60 62  1  0  0  0  0\n 58 63  1  0  0  0  0\n 63 64  2  0  0  0  0\n 63 65  1  0  0  0  0\n 65 66  1  0  0  0  0\n 66 67  1  0  0  0  0\n 67 68  1  0  0  0  0\n 67 69  2  0  0  0  0\nM  END\n","CompoundDescriptionComment":["Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24141993 http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018261s031lbl.pdf"],"DrugbankId":["DB00107"],"InVivoUseRoute":["Other"],"Iupac":["(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide"],"CompoundPatent":["JP4656725B2","JP2011528373A","JP2011526609A","JP2011511087A","JP2010209075A","JP2010117232A","JP2009543776A","JP2009532554A","JP2009520040A","JP2009215211A","JP2008533192A","JP2008069176A","JP2007537301A","JP2007525670A","JP2007517001A","JP2007509706A","JP2007508914A","JP2007508381A","JP2007505888A","JP2007505840A","JP2007504918A","JP2007501676A","JP2006528179A","JP2006515309A","JP2005504043A","JP2005130774A","JP2004507450A","JP2003517438A","JP2003502364A","JP2003335797A","JP2003334083A","JP2003292456A","JP2003277278A","JP2003226699A","JP2003146972A","JP2003070378A","JP2003047475A","JP2002544521A","JP2002534363A","JP2002521455A","JP2002516910A","JP2002322085A","JP2002138098A","JP2001302631A","JP2001261700A","JP2001233787A","JP2001139494A","JP2001055399A","JP2000351768A","JP2000191696A","JP2000095797A"],"CompoundDescription":["More than a century ago, Sir Henry Dale demonstrated that a component of the pituitary causes contractions of the mammalian uterus, hence his coining the term “oxytocic,” derived from the Greek for “quick birth,” for its activity. The discovery that a component of the pituitary causes milk secretion followed within a few years. By 1930, oxytocin was separated from vasopressin into pitocin and pitressin, respectively, at Parke Davis and made available for research. That a single peptide was responsible for these uterine and mammary actions was definitively confirmed upon the sequencing and synthesis of the peptide, 9 amino acids in length. Vincent du Vigneaud was awarded a Nobel Prize for this work. Oxytocin is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable for reasons of fetal or maternal concern, in order to achieve vaginal delivery. Oxytocin is indicated to produce uterine contractions during the third stage of labor and to control postpartum bleeding or hemorrhage. Uterine motility depends on the formation of the contractile protein actomyosin under the influence of the Ca2+- dependent phosphorylating enzyme myosin light-chain kinase. Oxytocin promotes contractions by increasing the intracellular Ca2+. Oxytocin has specific receptors in the myometrium and the receptor concentration increases greatly during pregnancy, reaching a maximum in early labor at term. The Oxytocin receptor is a typical class I G protein-coupled receptor that is primarily coupled via G(q) proteins to phospholipase C-beta. The high-affinity receptor state requires both Mg(2+) and cholesterol, which probably function as allosteric modulators. The agonist-binding region of the receptor has been characterized by mutagenesis and molecular modeling and is different from the antagonist binding site. The function and physiological regulation of the Oxytocin system is strongly steroid dependent."]},{"Synonyms":["Oxytocinum","Syntocinon","Oxymetrin","Syntometrine","Pitocin","Oxitocina","Cys-tyr-ile-gln-asn-cys-pro-leu-gly-nh2, cyclic 1-6 disulfide","Oxytocine","Cys-tyr-ile-gln-asn-cys-pro-leu-gly-nh2 (1-6)","Oxytocin"],"CompoundCID":["439302","5771"],"CompoundMOA":["Oxytocics"],"REFS":["Oxytocin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|EINECS (EU Inv of Exist.  Comm.  Chem  Sub)||--Systematic Name--","Oxytocin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|HSDB (Hazardous Substances Data Bank)||--Name of Substance--","Oxytocin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN:INN:BAN:JAN|--Name of Substance--","Oxitocina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|NLM (National Library of Medicine)||--Synonyms--","Oxitocina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|NLM (National Library of Medicine)|INN-Spanish|--Synonyms--","Oxytocin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|Drugs@FDA (FDA Drug Database)||--Synonyms--","Oxytocine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|NLM (National Library of Medicine)||--Synonyms--","Oxytocine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|NLM (National Library of Medicine)|INN-French|--Synonyms--","Oxytocinum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|NLM (National Library of Medicine)||--Synonyms--","Oxytocinum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|NLM (National Library of Medicine)|INN-Latin|--Synonyms--","Pitocin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|Drugs@FDA (FDA Drug Database)||--Synonyms--","Syntocinon|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|Drugs@FDA (FDA Drug Database)||--Synonyms--","UNII-1JQS135EYN|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|FDA SRS (FDA Substance Registration System)||--Synonyms--","Oxytocin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|MeSH (Medical Subject Headings File)||--MeSH Heading--","50-56-6|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000050566|PubMed Toxicology (Toxicology Citations From PubMed)||--CAS Registry Number--","Syntometrine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0037209624|MeSH (Medical Subject Headings File)||--Name of Substance--","Oxymetrin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0037209624|MeSH (Medical Subject Headings File)||--Synonyms--","Syntometrine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0037209624|NLM (National Library of Medicine)||--Synonyms--","37209-62-4|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0037209624|ChemIDPlus||--CAS Registry Number--","ClinicalTrials.gov||NCGC||","FDA DailyMed||NCGC||","NPC screening|NCGC00167132|NCGC||","Approved drugs||NCGC||","Human approved drugs||NCGC||","FDA approved||NCGC||","NPC informatics|NPC-7251694~Prestwick:PrestPep-7013~Sigma - ALDRICH:O6379~Sigma - SIGMA:SIGMA-O6379|NCGC||","FDA human approved||NCGC||","HTS amenable drugs||NCGC||HTS amenable drugs","QC spectra||NCGC||","50-56-6|OXYTOCIN|KEGG||","50-56-6|OXYTOCIN|Tariff||","50-56-6|Oxytocin|Japan||","OXYTOCIN|OXYTOCIN INJECTION, USP|Canada||","oxytocin|oxytocin|WHO essential||","OXYTOCIN|OXYTOCIN|KEGG||","Oxytocin|OXYTOCIN|KEGG||","Oxytocin|Oxytocin|UK NHS||","OXYTOCIN|OXYTOCIN|Tariff||","oxytocin|http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list13.pdf|INN||","OXYTOCIN|OXYTOCIN|FDA orange book||","OXYTOCIN|OXYTOCIN 10 USP UNITS IN DEXTROSE 5%|FDA orange book||","OXYTOCIN|OXYTOCIN 20 USP UNITS IN DEXTROSE 5%|FDA orange book||","OXYTOCIN|OXYTOCIN 5 USP UNITS IN DEXTROSE 5%|FDA orange book||","OXYTOCIN|PITOCIN|FDA orange book||","OXYTOCIN|SYNTOCINON|FDA orange book||","OXYTOCIN|SYNTOCINON|FDA drugs@FDA||","OXYTOCIN|OXYTOCIN|FDA drugs@FDA||","OXYTOCIN|PITOCIN|FDA drugs@FDA||","OXYTOCIN|OXYTOCIN 5 USP UNITS IN DEXTROSE 5%|FDA drugs@FDA||","OXYTOCIN|OXYTOCIN 20 USP UNITS IN DEXTROSE 5%|FDA drugs@FDA||","OXYTOCIN|OXYTOCIN 10 USP UNITS IN DEXTROSE 5%|FDA drugs@FDA||","Oxytocin|Oxytocin|Japan||","Oxytocin|Oxytocin|FDA green book||","OXYTOCIN|OXYTOCIN|FDA NDC||","oxytocinum|oxytocinum|INN2||","50-56-6|oxytocinum|INN2||"],"CompoundIndication":["Oxytocic"],"CURATIONS":["trung|NCGC|trung@jhu.edu|http://tripod.nih.gov|1307960524968","URL!","http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list13.pdf!","http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list13.pdf#page=8!","!","Pending!","CompoundDisplay!","CCC(C)C1NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(N)CSSCC(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(N)=O!","CCC(C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O!","!","Pending!"],"DATASET":["Canada","ClinicalTrials.gov","FDA DailyMed","NPC screening","Approved drugs","FDA orange book","Community curation","Human approved drugs","WHO essential","FDA approved","Tariff","KEGG","FDA NDC","FDA drugs@FDA","FDA green book","NPC informatics","UK NHS","FDA human approved","HTS amenable drugs","INN","QC spectra","Japan"],"SMILES":"CCC(C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O","URL":["http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list13.pdf#page=8"],"CompoundSpectra":["http://tripod.nih.gov/npc/spectra/NCGC00166145.png"],"CompoundUNII":["1JQS135EYN"],"CAS":["50-56-6","112457-76-8","37209-62-4"],"CLINICALTRIALS":["NCT00263796","NCT01256060","NCT00790062","NCT00891150","NCT00200252","NCT01243658","NCT01254045","NCT01152047","NCT00360048","NCT00540748","NCT00468520","NCT01183221","NCT01094028","NCT00975416","NCT01123317","NCT00490802"],"MOLFILE":"Oxytocin\n  Marvin  11091707412D          \n\n 69 71  0  0  1  0            999 V2000\n   -1.4880   -2.6556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.2330   -3.4403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.4261   -3.6118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1711   -4.3964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.1260   -2.9987    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   -0.6810   -2.8272    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.9359   -2.0425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.7429   -1.8710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.3839   -1.4294    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   -0.6389   -0.6448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.4458   -0.4733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.9979   -1.0864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.8048   -0.9149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.0598   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.8667    0.0413    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.5077    0.4829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.7008    0.3113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.4231   -1.6010    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.9751   -0.9879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.7201   -0.2033    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7821   -1.1594    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    2.0370   -1.9440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    2.3341   -0.5463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.1411   -0.7178    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\n    3.6931   -0.1047    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\n    4.5001   -0.2763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.7550   -1.0609    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    4.2030   -1.6740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    4.4579   -2.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.2649   -2.6301    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.9059   -3.0717    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    4.1608   -3.8563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9678   -4.0279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.5198   -3.4148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    5.2227   -4.8125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0989   -2.9002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    2.5469   -3.5133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8018   -4.2979    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7399   -3.3417    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    1.9948   -4.1264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.4428   -4.7395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.6978   -5.5241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.5047   -5.6956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    1.1457   -6.1372    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.1879   -3.9548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3809   -3.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.2947   -4.6038    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.5620   -1.2324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.8169   -2.0170    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    6.1140   -0.6193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    5.9425    0.1876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.6570    0.6001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.2701    0.0481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.9345   -0.7056    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    7.3470   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.9345   -2.1345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    8.1720   -1.4200    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5845   -2.1345    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    8.1720   -2.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5845   -3.5634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.4095   -3.5634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.1720   -4.2779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.4095   -2.1345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.8220   -1.4200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.8220   -2.8490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6470   -2.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.0595   -3.5634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.8845   -3.5634    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6470   -4.2779    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  1  0  0  0\n  5  3  1  1  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  7  8  2  0  0  0  0\n  7  9  1  0  0  0  0\n  9 10  1  6  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  0  0  0  0\n 12 13  1  0  0  0  0\n 13 14  2  0  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  2  0  0  0  0\n 11 17  1  0  0  0  0\n  9 18  1  0  0  0  0\n 18 19  1  0  0  0  0\n 19 20  2  0  0  0  0\n 19 21  1  0  0  0  0\n 21 22  1  6  0  0  0\n 21 23  1  0  0  0  0\n 23 24  1  0  0  0  0\n 24 25  1  0  0  0  0\n 25 26  1  0  0  0  0\n 26 27  1  0  0  0  0\n 27 28  1  0  0  0  0\n 28 29  1  0  0  0  0\n 29 30  2  0  0  0  0\n 29 31  1  0  0  0  0\n 31 32  1  6  0  0  0\n 32 33  1  0  0  0  0\n 33 34  1  0  0  0  0\n 33 35  2  0  0  0  0\n 31 36  1  0  0  0  0\n 36 37  1  0  0  0  0\n 37 38  2  0  0  0  0\n 37 39  1  0  0  0  0\n 39 40  1  1  0  0  0\n 40 41  1  0  0  0  0\n 41 42  1  0  0  0  0\n 42 43  1  0  0  0  0\n 42 44  2  0  0  0  0\n 39 45  1  0  0  0  0\n 45 46  1  0  0  0  0\n  5 46  1  0  0  0  0\n 46 47  2  0  0  0  0\n 27 48  1  1  0  0  0\n 48 49  2  0  0  0  0\n 48 50  1  0  0  0  0\n 50 51  1  0  0  0  0\n 51 52  1  0  0  0  0\n 52 53  1  0  0  0  0\n 53 54  1  0  0  0  0\n 50 54  1  0  0  0  0\n 54 55  1  1  0  0  0\n 55 56  2  0  0  0  0\n 55 57  1  0  0  0  0\n 58 57  1  6  0  0  0\n 58 59  1  0  0  0  0\n 59 60  1  0  0  0  0\n 60 61  1  0  0  0  0\n 60 62  1  0  0  0  0\n 58 63  1  0  0  0  0\n 63 64  2  0  0  0  0\n 63 65  1  0  0  0  0\n 65 66  1  0  0  0  0\n 66 67  1  0  0  0  0\n 67 68  1  0  0  0  0\n 67 69  2  0  0  0  0\nM  END\n","name":"Oxytocin","CompoundDrugLabelRx":["10019-291;Oxytocin;injection;OXYTOCIN;10 [USP'U] in 1 mL;1JQS135EYN","42023-116;Pitocin;injection;oxytocin;10 [USP'U] in 1 mL;1JQS135EYN","0703-6275;Oxytocin;injection;Oxytocin;100 [USP'U] in 10 mL;1JQS135EYN","0703-6271;Oxytocin;injection;Oxytocin;10 [USP'U] in 1 mL;1JQS135EYN","0078-0060;Syntocinon;injection, solution;oxytocin;10 [iU] in 1 mL;1JQS135EYN","60793-267;Pitocin;injection;oxytocin;100 UNITS in 10 mL;1JQS135EYN","60793-265;Pitocin;injection;oxytocin;10 UNITS in 1 mL;1JQS135EYN","0591-3553;Pitocin;injection;oxytocin;10 UNITS in 1 mL;1JQS135EYN"],"ID":["TBZ"],"id":"TBZ"},{"Chemical Name":"Oxytocin (a complex peptide)","CAS":"50-56-6","Raw Materials":"Ammonia\nBenzyl-L-proline hydrochloride\nGlycine lower alkyl ester\nHydrogen\nHydrogen chloride\nL-Isoleucine lower alkyl ester\nL-Leucine lower alkyl ester\nL-Tyrosine lower alkyl ester\nN-Trityl glutamic acid-γ-lower alkyl ester\nS,N-Ditrityl-L-cysteine diethylamine salt\nα-Benzyl-L-aspartic acid-α-lower alkyl ester","References":"Merck Index 6849\nKleeman & Engel p. 681\nPDR pp. 1382, 1596, 1966, 1989\nI.N. p. 722\nREM pp. 949, 957\nVelluz, L., Amiard, G., Bartos, J., Goffinet, B. and Heymes, R.; US Patent\n2,938,891; May 31, 1960; assigned to Uclaf, France\nVelluz, L., Amiard, G. and Heymes, R.; US Patent 3,076,797; February 5,\n1963; assigned to Roussel-UCLAF SA, France","UNII PT":"Oxytocin","id":"1JQS135EYN","Drug Products":"eyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiU3ludG9jaW5vbiIsIlllYXIgSW50cm9kdWNlZCI6IjE5NTciLCJDb21wYW55IjoiU2FuZG96In0=\neyJDb3VudHJ5IjoiRnJhbmNlIiwiUHJvZHVjdCI6IlN5bnRvY2lub24iLCJZZWFyIEludHJvZHVjZWQiOiIxOTU4IiwiQ29tcGFueSI6IlNhbmRveiJ9\neyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiVXRlcmFjb24iLCJZZWFyIEludHJvZHVjZWQiOiIxOTY0IiwiQ29tcGFueSI6IkhvZWNoc3QifQ==\neyJDb3VudHJ5IjoiSmFwYW4iLCJQcm9kdWN0IjoiQXRvbmluLU8iLCJDb21wYW55IjoiVGVpa29rdSBab2tpIn0=\neyJDb3VudHJ5IjoiSXRhbHkiLCJQcm9kdWN0IjoiRW5kb3BpdHVpdHJpbmEiLCJDb21wYW55IjoiSS5TLk0uIn0=\neyJDb3VudHJ5IjoiVy4gR2VybWFueSIsIlByb2R1Y3QiOiJPcmFzdGhpbiIsIkNvbXBhbnkiOiJIb2VjaHN0In0=\neyJDb3VudHJ5IjoiSXRhbHkiLCJQcm9kdWN0IjoiT3hpdG9jaW4iLCJDb21wYW55IjoiQ2hpbm9pbiJ9\neyJQcm9kdWN0IjoiT3h5c3RpbiJ9\neyJQcm9kdWN0IjoiT3h5dGFsIn0=\neyJQcm9kdWN0IjoiUGFydG9jb24ifQ==\neyJQcm9kdWN0IjoiUGFydG9sYWN0In0=\neyJQcm9kdWN0IjoiUGl0b2NpbiJ9\neyJQcm9kdWN0IjoiUGl0dWl0YW4ifQ==","Drug Substance":"Oxytocin","UNII":"1JQS135EYN","Therapeutic Function":"Oxytocic"},{"EVMPD":"SUB09580MIG","WHO-ESSENTIAL MEDICINES LIST":"22.1","ActiveMoieties":"1JQS135EYN","ECHA (EC/EINECS)":"200-048-4","WHO-ATC":["G02AC01","H01BB02"],"INN":"1480","MESH":"D010121","CFR":"21 CFR 522.1680","MERCK INDEX":"M8348","WIKIPEDIA":"OXYTOCIN","NCI_THESAURUS":"C724","ChEMBL":"CHEMBL395429","PreferredName":"OXYTOCIN","id":"1JQS135EYN","WHO-VATC":["QH01BB02","QG02AC90","QG02AC01"],"UNII":"1JQS135EYN","Synonyms":["OXYTOCIN [JAN]","ALPHA-HYPOPHAMINE [WHO-IP]","UTERACON","INTERTOCINE S","ENDOPITUITRINA","OXYTOCINUM [WHO-IP LATIN]","OXYTOCIN [WHO-IP]","GLYCINAMIDE, L-CYSTEINYL-L-TYROSYL-L-ISOLEUCYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LEUCYL-, CYCLIC (1->6)-DISULFIDE","OXYTOCIN [VANDF]","OXYTOCIN [WHO-DD]","OXYTOCIN [USP-RS]","OXYTOCIN [HSDB]","OXYTOCIN [GREEN BOOK]","OXYTOCIN [MI]","OXYTOCIN [MART.]","OXYTOCIN [ORANGE BOOK]","OXYTOCIN [USP]","OXYTOCIN [EP]","OXYTOCIN [INN]","SYNTOCINON","PITOCIN","OXYTOCIN"],"NDF-RT":["N0000009705","N0000175828","N0000006473"],"HSDB":"50-56-6","PUBCHEM":"439302","LactMed":"50-56-6","WHO INTERNATIONAL PHARMACOPEIA":"OXYTOCIN","IUPHAR":"2174","CAS":"50-56-6","DRUG BANK":"DB00107","References":["WEBSITE","JAN","OXYTOCIN [WHO-IP]","OXYTOCIN [VANDF]","OXYTOCIN [WHO-DD]","OXYTOCIN [USP-RS]","OXYTOCIN [HSDB]","OXYTOCIN [GREEN BOOK]","OXYTOCIN [MI]","OXYTOCIN [MART.]","OXYTOCIN [ORANGE BOOK]","OXYTOCIN [USP]","OXYTOCIN [EP]","OXYTOCIN [INN]","SRS import [1JQS135EYN]","SRS CODE IMPORT","SCIFINDER","WHO-IP","STN","NDF-RT","WHO-DD","USP/NF","HSDB","FDA SRS 2011","MERCK INDEX","MARTINDALE 2011","ORANGE BOOK 2011","USP 33","EP 7.2","INN 2010","USP Dictionary 2010"],"EPA CompTox":"50-56-6","Class":"protein","RXCUI":"7824"},{"Synonyms":["OXYTOCIN IDENTIFICATION","OXYTOCIN IDENTIFICATION [USP-RS]","OXYTOCIN, ACETATE (1:1)","OXYTOCIN MONOACETATE","OXYTOCIN, MONOACETATE (SALT)","OXYTOCIN ACETATE"],"CAS":"6233-83-6","ActiveMoieties":"1JQS135EYN","References":["WEBSITE","OXYTOCIN IDENTIFICATION [USP-RS]","SRS import [4NR672T8NL]","SRS CODE IMPORT","USP-RS","FDA_SRS","STN"],"EPA CompTox":"6233-83-6","PUBCHEM":"12004215","Class":"protein","PreferredName":"OXYTOCIN ACETATE","id":"4NR672T8NL","RXCUI":"1733680","UNII":"4NR672T8NL"},{"Synonyms":["OXYTOCIN, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1) (SALT)","OXYTOCIN CITRATE [WHO-DD]","PITOCIN-BUCCAL","BUCCAL","PITOCIN CITRATE","OXYTOCIN, CITRATE","OXYTOCIN, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (SALT)","OXYTOCIN CITRATE"],"CAS":"74499-03-9","EVMPD":"SUB23136","ActiveMoieties":"1JQS135EYN","ECHA (EC/EINECS)":"277-888-3","References":["OXYTOCIN CITRATE [WHO-DD]","SRS import [1573L6WJ8U]","SRS CODE IMPORT","WHO-DD","STN"],"PUBCHEM":"72941595","Class":"protein","PreferredName":"OXYTOCIN CITRATE","id":"1573L6WJ8U","UNII":"1573L6WJ8U"}]}